[Immunosuppressive therapy of glomerulotubular lesions in childhood].
D000208:Acute Disease; D001379:Azathioprine / Q000627:therapeutic use*; D001772:Blood Cell Count; D001798:Blood Proteins / Q000032:analysis; D001799:Blood Sedimentation; D002648:Child; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D003864:Depression, Chemical; D004920:Erythropoiesis / Q000187:drug effects; D005921:Glomerulonephritis / Q000188:drug therapy*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000276:immunology; D007677:Kidney Function Tests; D007958:Leukocyte Count; D007970:Leukopenia / Q000139:chemically induced; D008214:Lymphocytes / Q000187:drug effects; D008231:Lymphopenia / Q000139:chemically induced; D009395:Nephritis, Interstitial / Q000097:blood / Q000188:drug therapy*; D009402:Nephrosis, Lipoid / Q000097:blood / Q000188:drug therapy*; D013997:Time Factors
D001798:Blood Proteins; D006454:Hemoglobins; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine
Immunsuppressivtheraphie bei glomerulo-tubulären Affektionen im Kindesalter.